We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Collaboration with Algeria to Expand Cancer Treatment Services

By MedImaging International staff writers
Posted on 05 Feb 2014
Print article
Varian Medical Systems (Palo Alto, CA, USA) has entered into an agreement with the Algerian Government’s Ministry of Health that will include the provisioning of six cancer treatment centers with USD 51 million of the latest technology for radiotherapy and radiosurgery. Varian will also establish a local unit to provide a wide range of services as well as a regional training and education center.

“We are delighted and honored to partner with the Algerian Ministry to bring Varian’s latest technologies in treatment planning and delivery for the benefit of cancer patients in this important region,” said Kolleen Kennedy, president of Varian’s oncology systems business. “We look forward to working closely with the radiation oncology community in Algeria to implement the most advanced techniques in radiotherapy and radiosurgery.”

Varian will provide each of six cancer treatment centers with three medical linear accelerators, including a TrueBeam STx radiosurgery unit, in addition to Eclipse treatment planning and ARIA oncology information management software. These will be the first TrueBeam systems in Northern Africa. Varian plans to establish a parts depot in Algeria to make system components and tools readily available to service Varian equipment as needed.

The agreement also calls for Varian to establish a regional training and education “Center of Excellence” to serve as a training hub for the region. Programs at the center will be designed to help clinicians develop the skills for using Varian technology to deliver advanced radiotherapy treatments.

Currently, Varian has an installed base of six treatment systems in Algeria, having installed its first medical linear accelerator there nearly 25 years ago. “This partnership builds on the long-standing, strong relationship we have with the Algerian Ministry of Health,” Ms. Kennedy added. “The Ministry of Health is clearly committed to expanding patient access to quality care. They are creating a solid foundation to address a growing need for advanced cancer treatment capability. We would also like to acknowledge the United States Embassy and US Department of Commerce for invaluable assistance they provided as we worked to develop this important partnership.”

Varian will begin installing technology in 2014 and expects to book approximately half of the orders in the second quarter of fiscal 2014. “The Algerian Ministry of Health is looking forward to working with Varian to offer the people of Algeria some of the world’s most advanced cancer fighting technology, together with training facilities that will help prepare local clinicians to offer quality treatments safely and effectively,” said Slim Belkessam, advisor to the Algerian Health Minister.

Varian Medical Systems is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing cancer clinics, radiotherapy centers, and medical oncology practices.

Related Links:

Varian Medical Systems


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
X-Ray Detector
FDR-D-EVO III
Color Doppler Ultrasound System
DRE Crystal 4PX
Ultrasound Doppler System
Doppler BT-200

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

General/Advanced Imaging

view channel
Image: The Tyche machine-learning model could help capture crucial information. (Photo courtesy of 123RF)

New AI Method Captures Uncertainty in Medical Images

In the field of biomedicine, segmentation is the process of annotating pixels from an important structure in medical images, such as organs or cells. Artificial Intelligence (AI) models are utilized to... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.